Anti-myostatin

Clinical trials for Anti-myostatin explained in plain language.

Never miss a new study

Get alerted when new Anti-myostatin trials appear

Sign up with your email to follow new studies for Anti-myostatin, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet finished but already full! 1 Completed 1

Can a muscle-boosting antibody help people with spinal muscular atrophy over the long haul?

Disease control Ongoing

This trial tests the long-term safety and effectiveness of apitegromab, an investigational antibody that blocks myostatin, a protein that limits muscle growth. People with type 2 or type 3 spinal muscular atrophy who completed earlier apitegromab studies can join. Researchers wil…

Matched conditions: ANTI-MYOSTATIN

Phase 3 • Sponsor: Scholar Rock, Inc. • Aim: Disease control

Last updated Sep 03, 2026 00:00 UTC

Anti-myostatin

Get alerted when new Anti-myostatin trials appear

Can a muscle-boosting antibody help people with spinal muscular atrophy over the long haul?